The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown

References

• Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D. The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges; 2020. Available from: https://www.commonwealthfund.org/publications/2020/apr/impact-covid-19-outpatient-visits. Accessed August 5, 2021.
   Google Scholar
• Safadi K, Kruger JM, Chowers I, et al. Ophthalmology practice during the COVID-19 pandemic. BMJ Open Ophthalmol. 2020;5(1):e000487. doi:10.1136/bmjophth-2020-000487
   PubMed Web of Science ®Google Scholar
• Agarwal D, Kumar A. Managing intravitreal injections in adults in COVID-19 and post-COVID-19 era- Initial experiences. Indian J Ophthalmol. 2020;68(6):1216–1218. doi:10.4103/ijo.IJO_1391_20
   Web of Science ®Google Scholar
• Syed AAO, Jahan S, Aldahlaw AA, Alghazzawi EA. Preventive practices of ophthalmologists during COVID-19 pandemic. Clin Ophthalmol. 2021;15:1267–1275. doi:10.2147/OPTH.S295730
   PubMed Web of Science ®Google Scholar
• Wasser LM, Weill Y, Brosh K, et al. The impact of COVID-19 on intravitreal injection compliance. SN Compr Clin Med. 2020;2:1–4. doi:10.1007/s42399-020-00614-4.
   Google Scholar
• Mansour SE, Browning DJ, Wong K, Flynn HW, Bhavsar AR. The evolving treatment of diabetic retinopathy. Clin Ophthalmol. 2020;14:653–678. doi:10.2147/OPTH.S236637
   PubMed Web of Science ®Google Scholar
• Romano F, Monteduro D, Airaldi M, et al. Increased number of submacular hemorrhages as a consequence of coronavirus disease 2019 lockdown. Ophthalmol Retina. 2020;4(12):1209–1210. doi:10.1016/j.oret.2020.06.027
   PubMedGoogle Scholar
• Ashkenazy N, Goduni L, Smiddy WE. Short-term effects of COVID-19-related deferral of intravitreal injection visits. Clin Ophthalmol. 2021;15:413–417. doi:10.2147/OPTH.S296345
   PubMed Web of Science ®Google Scholar
• Yang KB, Feng H, Zhang H. Effects of the COVID-19 pandemic on anti-vascular endothelial growth factor treatment in China. Front Med. 2020;7:576275. doi:10.3389/fmed.2020.576275
   Web of Science ®Google Scholar
• Carnevali A, Giannaccare G, Gatti V, Scuteri G, Randazzo G, Scorcia V. Intravitreal injections during COVID-19 outbreak: real-world experience from an Italian tertiary referral center. Eur J Ophthalmol. 2021;31(1):10–12. doi:10.1177/1120672120962032
   PubMed Web of Science ®Google Scholar
• Breazzano MP, Nair AA, Arevalo JF, et al. Frequency of urgent or emergent vitreoretinal surgical procedures in the United States during the COVID-19 pandemic. JAMA Ophthalmol. 2021;139(4):456. doi:10.1001/jamaophthalmol.2021.0036
   PubMed Web of Science ®Google Scholar
• Borrelli E, Grosso D, Vella G, et al. Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”. Graefes Arch Clin Exp Ophthalmol. 2020;258(12):2655–2660. doi:10.1007/s00417-020-04858-7
   PubMed Web of Science ®Google Scholar
• Legrottaglie EF, Balia L, Camesasca FI, et al. Management of an ophthalmology department during COVID-19 pandemic in Milan, Italy. Eur J Ophthalmol. 2020:1120672120960334. doi:10.1177/1120672120960334.
   Web of Science ®Google Scholar
• Xu D, Starr MR, Boucher N, et al. Real-world vitreoretinal practice patterns during the 2020 COVID-19 pandemic: a nationwide, aggregated health record analysis. Curr Opin Ophthalmol. 2020;31(5):427–434. doi:10.1097/ICU.0000000000000692
   PubMed Web of Science ®Google Scholar
• dell’Omo R, Filippelli M, Semeraro F, et al. Effects of the first month of lockdown for COVID-19 in Italy: a preliminary analysis on the eyecare system from six centers. Eur J Ophthalmol. 2020. doi:10.1177/1120672120953074.
   Web of Science ®Google Scholar
• dell’Omo R, Filippelli M, Virgili G, et al. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: a report from 39 institutional centers. Eur J Ophthalmol. 2021. doi:10.1177/11206721211002442.
   Web of Science ®Google Scholar
• El Hamichi S, Gold A, Heier J, Kiss S, Murray TG. Impact of the COVID-19 pandemic on essential vitreoretinal care with three epicenters in the United States. Clin Ophthalmol. 2020;14:2593–2598. doi:10.2147/OPTH.S267950
   Web of Science ®Google Scholar
• Billioti de Gage S, Drouin J, Desplas D, et al. Intravitreal anti-vascular endothelial growth factor use in France during the coronavirus disease 2019 pandemic. JAMA Ophthalmol. 2021;139(2):240–242. doi:10.1001/jamaophthalmol.2020.5594
   PubMed Web of Science ®Google Scholar
• Babu N, Kohli P, Mishra C, et al. To evaluate the effect of COVID-19 pandemic and national lockdown on patient care at a tertiary-care ophthalmology institute. Indian J Ophthalmol. 2020;68(8):1540–1544. doi:10.4103/ijo.IJO_1673_20
   Web of Science ®Google Scholar
• Health Equity. U.S. Department of Veteran Affairs. Available from: https://www.research.va.gov/topics/health_equity.cfm. Accessed May 29, 2021.
   Google Scholar
• Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed August 5, 2021.
   Google Scholar
• Hoerster KD, Lehavot K, Simpson T, McFall M, Reiber G, Nelson KM. Health and health behavior differences: U.S. Military, veteran, and civilian men. Am J Prev Med. 2012;43(5):483–489. doi:10.1016/j.amepre.2012.07.029
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• IBM SPSS Statistics for Windows. Version 27.0. 2020.
   Google Scholar
• Lindeke-Myers A, Zhao PYC, Meyer BI, et al. Patient perceptions of SARS-CoV-2 exposure risk and association with continuity of ophthalmic care. JAMA Ophthalmol. 2021;139(5):508. doi:10.1001/jamaophthalmol.2021.0114
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–1431. doi:10.1056/NEJMoa054481
   PubMed Web of Science ®Google Scholar
• Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–1444. doi:10.1056/NEJMoa062655
   PubMed Web of Science ®Google Scholar
• Kiss S, Campbell J, Almony A, et al. Management and outcomes for neovascular age-related macular degeneration: analysis of United States electronic health records. Ophthalmology. 2020;127(9):1179–1188. doi:10.1016/j.ophtha.2020.02.027
   Web of Science ®Google Scholar
• American Academy of Ophthalmology. Available from: https://www.aao.org/headline/new-recommendations-urgent-nonurgent-patient-care. Accessed April 1, 2021.
   Google Scholar
• Viola F, Milella P, Giuffrida FP, Ganci S, Invernizzi A. The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases: report from a referral hospital in Milan. Retina. 2020;41:701–706. doi:10.1097/IAE.0000000000002941
   Web of Science ®Google Scholar
• Karaca-Mandic P, Georgiou A, Sen S. Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states. JAMA Intern Med. 2020;181:131–134. doi:10.1001/jamainternmed.2020.3857
   Web of Science ®Google Scholar
• Macias Gil R, Marcelin JR, Zuniga-Blanco B, Marquez C, Mathew T, Piggott DA. COVID-19 pandemic: disparate health impact on the hispanic/latinx population in the United States. J Infect Dis. 2020;222(10):1592–1595. doi:10.1093/infdis/jiaa474
   PubMed Web of Science ®Google Scholar
• Understanding the ASVAB Test. U.S. army; 2021. Available from: https://www.goarmy.com/learn/understanding-the-asvab.html. Accessed May 25, 2021.
   Google Scholar
• Moussa M, Elshorbagy MS, Emarah A, et al. Intravitreal injections of anti-VEGF agents during COVID-19 pandemic: clinical audit from Tanta University Hospital. Int Ophthalmol. 2021;41:1437–1443. doi:10.1007/s10792-021-01719-y
   Web of Science ®Google Scholar
• Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020;324(1):96–99. doi:10.1001/jama.2020.9972
   PubMed Web of Science ®Google Scholar
• Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol. 2021;77(2):159–169. doi:10.1016/j.jacc.2020.10.055
   PubMed Web of Science ®Google Scholar
• Press VG, Gershon AS, Sciurba FC, Blagev DP. Concerns about coronavirus disease-related collateral damage for patients with COPD. Chest. 2020;158(3):866–868. doi:10.1016/j.chest.2020.05.549
   PubMed Web of Science ®Google Scholar
• Arora N, Lowe D, Sarsour N, et al. Asthma care during COVID-19: differences in attitudes and expectations between physicians and patients. J Asthma. 2021:1–7. doi:10.1080/02770903.2021.1887214.
   Web of Science ®Google Scholar
• Aragona M, Barbato A, Cavani A, Costanzo G, Mirisola C. Negative impacts of COVID-19 lockdown on mental health service access and follow-up adherence for immigrants and individuals in socio-economic difficulties. Public Health. 2020;186:52–56. doi:10.1016/j.puhe.2020.06.055
   PubMed Web of Science ®Google Scholar
• Carnevali A, Giannaccare G, Gatti V, Scuteri G, Randazzo G, Scorcia V. Intravitreal injections during COVID-19 outbreak: real-world experience from an Italian tertiary referral center. Eur J Ophthalmol. 2020. doi:10.1177/1120672120962032
   Web of Science ®Google Scholar